TSXV:BTI.H - Post by User
Comment by
OttawaPeteron Jan 20, 2023 3:20pm
82 Views
Post# 35236312
RE:RE:RE:RE:RE:RE:RE:RE:RE:Consequences of a "no" vote: from IR
RE:RE:RE:RE:RE:RE:RE:RE:RE:Consequences of a "no" vote: from IR
prophetoffactz wrote: "Md got a heck of a lot more done than DR"
Incredibly hard to argue that.
Rathjen's Chiesi deal beats Day's Prothena deal.
Rathjen delivered more deals and evaluations(Chiesi, J&J, Neuramedy, Daiichi, Oxyrane, Aposense, and potentially Ellipses) than Day(Prothena, undisclosed major pharma).
Rathjen dellvered more transformational deals(Cresence, Biodexa).
Day failed to advance xB3 into the clinic as Rathjen, and put BTI in a financial mess as Rathjen but atleast Rathjen has the balls to address the disaster and put the company on a viable path with the Biodexa deal and potential US$20 million in financing. Rathjen may finally get BTI on NASDAQ too which Day failed to do. Biodexa also significantly strengthens BTI with scale, resources, and complementary assets. Biodexa could have the backing on important fund like Armistice Capital as a major shareholder. Day didn't deliver one major backer like this. If Day had the force of character to correct BTI's course as Rathjen is now demonstrating BTI could be in a much healthier place today.
P.S. POF's shadow is reflecting in the lake & the once again paid shill clearly swallowed a bitter pill.